These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 8188455)

  • 1. Possible role of defibrotide in endothelial cell protection.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Int J Tissue React; 1993; 15(4):157-61. PubMed ID: 8188455
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Defibrotide, a stimulator of prostacyclin (PGI2) production, prevents the effects of ischaemic damage.
    Ferrero ME; Marni A; Rovati M; Aimini R; Salari PC; Gaja G
    Int J Tissue React; 1989; 11(4):179-84. PubMed ID: 2517498
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prostacyclin release from endothelial cells, induced by defibrotide treatment, favours the function of grafted rat hearts and kidneys.
    Ferrero ME; Marni A; Salari PC; Spaggiari PG; Gaja G
    Int J Tissue React; 1991; 13(4):215-8. PubMed ID: 1821415
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiischaemic effect of defibrotide treatment in rat kidney.
    Corsi M; Parise M; Gaja G; Ferrero ME
    Drugs Exp Clin Res; 1993; 19(6):261-5. PubMed ID: 8013269
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Stimulation of endogenous prostacyclin protects the reperfused pig myocardium from ischemic injury.
    Hohlfeld T; Strobach H; Schrör K
    J Pharmacol Exp Ther; 1993 Jan; 264(1):397-405. PubMed ID: 8423539
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of defibrotide on prostacyclin release from isolated rabbit kidneys and protection from post-ischemic acute renal failure in vivo.
    Berti F; Rossoni G; Bianchi G; Alberico P; Tettamanti R; Calvani AB; Mantovani M; Prino G
    Eicosanoids; 1991; 4(4):209-15. PubMed ID: 1789997
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of kidney from postischemic reperfusion injury in rats treated with defibrotide.
    Marni A; Ferrero ME; Rovati M; Salari PC; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2226-9. PubMed ID: 2171165
    [No Abstract]   [Full Text] [Related]  

  • 8. Defibrotide as a possible anti-ischemic drug.
    Coccheri S; Nazzari M
    Semin Thromb Hemost; 1996; 22 Suppl 1():9-14. PubMed ID: 8807722
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Defibrotide use during preservation favors the metabolic function of grafted kidneys in rats.
    Ferrero ME; Corsi M; Parise M; Marni A; Gaja G
    Transplant Proc; 1993 Aug; 25(4):2531-3. PubMed ID: 8356656
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug-induced in vitro inhibition of neutrophil-endothelial cell adhesion.
    Pellegatta F; Lu Y; Radaelli A; Zocchi MR; Ferrero E; Chierchia S; Gaja G; Ferrero ME
    Br J Pharmacol; 1996 Jun; 118(3):471-6. PubMed ID: 8762067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defibrotide, a profibrinolytic drug, reduces damage due to post-ischaemic reperfusion in rats.
    Ferrero ME; Marni A; Gaja G
    Biochem Soc Trans; 1990 Jun; 18(3):501-2. PubMed ID: 2373250
    [No Abstract]   [Full Text] [Related]  

  • 12. Efficacy of defibrotide treatment in favoring the function of the grafted heart and kidney in rats.
    Ferrero ME; Corsi M; Marni A; Gaja G
    Transplant Proc; 1994 Feb; 26(1):251-2. PubMed ID: 8108964
    [No Abstract]   [Full Text] [Related]  

  • 13. The anti-ischemic drugs defibrotide and oligotide analogously inhibit leukocyte-endothelial cell adhesion in vitro.
    Pellegatta F; Ferrero E; Marni A; Chierchia S; Forti D; Ferrero ME
    Transpl Int; 1996; 9 Suppl 1():S420-4. PubMed ID: 8959877
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Defibrotide: properties and clinical use of an old/new drug.
    Pescador R; Capuzzi L; Mantovani M; Fulgenzi A; Ferrero ME
    Vascul Pharmacol; 2013; 59(1-2):1-10. PubMed ID: 23680861
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of defibrotide, a novel oligodeoxyribonucleotide, on ischaemia and reperfusion injury of the rat liver.
    Kim KJ; Shin YK; Song JH; Oh BK; Choi MS; Sohn UD
    Auton Autacoid Pharmacol; 2002 Feb; 22(1):37-46. PubMed ID: 12423425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of rat heart from damage due to ischemia-reperfusion during procurement and grafting by defibrotide.
    Ferrero ME; Marni A; Parise M; Salari PC; Gaja G
    Transplantation; 1991 Oct; 52(4):611-5. PubMed ID: 1926339
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protection of the ischaemic myocardium from reperfusion injury by defibrotide and its possible mechanism of action.
    Thiemermann C; Ney P; Schrör K
    Biomed Biochim Acta; 1988; 47(10-11):S19-22. PubMed ID: 3248105
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Endothelial protection by defibrotide--a new strategy for treatment of myocardial infarction?
    Schrör K; Ackermann G; Hohlfeld T; Löbel P; Ney P; Schröder H; Strobach H
    Z Kardiol; 1989; 78 Suppl 6():35-41. PubMed ID: 2559554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Are increased ATP blood levels responsible for PGI2 release from endothelium?
    Salari PC; Marni A; Parisé M; Calvani AB; Spaggiari PG; Gaja G; Ferrero ME
    Int J Tissue React; 1991; 13(4):219-23. PubMed ID: 1668237
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Improved metabolic function of rat heart during procurement using defibrotide.
    Ferrero ME; Marni A; Aimini R; Bergamasco E; Gaja G
    Transplant Proc; 1990 Oct; 22(5):2230-2. PubMed ID: 2171166
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.